Newsfeeds Archive - Page 5 of 5

2 minute read

News

ASLAN Pharmaceuticals Signs License Agreement With Belle.ai To Use belleStudy Image Capture Software In Atopic Dermatitis Clinical Trials

August 25, 7:08 AM

BelleTorus Corporation (“Belle.ai”) and ASLAN Pharmaceuticals (NASDAQ:ASLN), today announced that ASLAN has licensed belleStudy™ digital image capture software in support of ASLAN’s clinical

ASLN

8 minute read

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday

By Lisa Levin

August 15, 3:43 AM

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

ACRX

3 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

August 12, 1:56 PM

APTX

1 minute read

News

Aslan Pharmaceuticals Pte. Ltd. (Singapore, SG) Granted U.S. Patent #11,382,903 for Cancer therapy

By Charles Gross

July 12, 6:39 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6615&f=G&l=50&d=PTXT&p=133&S1=20220712&OS=20220712&RS=20220712

ASLN

Latest news

ASLAN Pharmaceuticals Signs License Agreement With Belle.ai To Use belleStudy Image Capture Software In Atopic Dermatitis Clinical Trials

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday

12 Health Care Stocks Moving In Friday’s Intraday Session

Aslan Pharmaceuticals Pte. Ltd. (Singapore, SG) Granted U.S. Patent #11,382,903 for Cancer therapy